Search

Your search keyword '"Soria, Angèle"' showing total 108 results

Search Constraints

Start Over You searched for: Author "Soria, Angèle" Remove constraint Author: "Soria, Angèle" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Language english Remove constraint Language: english
108 results on '"Soria, Angèle"'

Search Results

1. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

3. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

4. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study

5. In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study

6. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes

7. Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study

8. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study

9. Successful treatment of JAK1-associated inflammatory disease

11. Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study

13. Paradoxical urticaria to H1‐antihistamines.

14. Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial.

15. Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study.

16. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

19. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

22. Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population

23. Guidelines for cold urticaria management established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology.

24. A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial – the PRADA trial

25. Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch tests with an essential oil series. Results of a French study of the DAG (Dermato‐Allergology group of the French Society of Dermatology).

27. Risk stratification through extensive allergy work‐up in COVID‐19‐mRNA vaccine allergic reactions.

30. Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort.

31. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study.

32. Allergic contact dermatitis caused by PEG‐22 and PEG‐45 dodecyl glycol copolymers in two skin‐repairing creams.

34. Chemical characterization of inks in skin reactions to tattoo.

35. What is the optimal duration for a ROAT? The experience of the French Dermatology and Allergology group (DAG).

36. Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper.

38. Chronic inducible urticaria a particular form of chronic urticaria.

39. Skin tests in the work‐up of cutaneous adverse drug reactions: A review and update.

42. General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France.

45. Sweet‐like syndrome and multiple COVID arm syndrome following COVID‐19 vaccines: 'specific' patterns in a series of 192 patients.

46. Dysregulation of microRNA expression in the skin during cutaneous adverse drug reactions.

47. Vocational Guidance for Young Patients with Atopic Dermatitis: A Survey of Physicians' Opinions and Practices.

48. Occurrence of immediate and delayed hypersensitivity to hexamidine.

49. Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.

50. Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trial.

Catalog

Books, media, physical & digital resources